Das Klinikum

Dr Oliver Feeney

Dr Oliver Feeney

Akademischer Mitarbeiter

Kontakt

Telefonnummer: 07071 29-78031

E-Mail-Adresse: oliver.feeney@uni-tuebingen.de

Klinik / Institut / Zentrum

  • Ethical, legal and social justice implications of new biotechnologies, esp. genome editing in humans; human enhancement technologies.
  • Biotech patents, ethical licencing and novel regulation of new technologies.
  • Deliberative engagement and building trust in science and medicine (e.g. future technologies, genome editing, vaccines).
  • ELSI analysis of migrant-centred electronic health records.
  • New challenges in healthcare ethics – bridging theory and practice.
  • Non-ideal theories of distributive justice and multidisciplinary approaches.
  • 'Genome Editing Dilemma: Navigating Dual-Use Potential and Charting the Path Forward', Ana Ruxandra Badea & Oliver Feeney, Journal of Bioethical Inquiry (2024): https://doi.org/10.1007/s11673-024-10358-8
  • 'Catching the next wave? The relationship between UNESCO and developments in genomics'. European Journal of Human Genetics 32, 605–606 (2024). https://doi.org/10.1038/s41431-024-01621-y
  • 'Genetics and Justice, non-ideal theory and the role of patents' (2023) in S.Slokenberga, T. Minssen & A. Nordberg (eds) Governing, Protecting, and Regulating the Future of Genome Editing: the significance of ELSPI perspectives. Koninklijke Brill NV. Leiden, The Netherlands.
  • 'European eHealth Responses to Crisis Migration: A Critical Appraisal', Oliver Feeney, Gabriele Werner-Felmayer, Helena Siipi, Markus Frischhut, Silvia Zullo, Ursela Barteczko, Lars Øystein Ursin, Shai Linn, Heike Felzmann, Dušanka Krajnović, John Saunders, and Vojin Rakić. (2022). In A. Hellemeyer & E. Díaz-Amado (Eds.), Forced Displacement in Conflict Scenarios: Ethics and HumanRights Perspectives (pp. 106–118). Editorial Pontificia Universidad Javeriana. [eBook] https://doi.org/10.11144/Javeriana.9789587817133
  • 'Genetics and Justice, Non-ideal theory and the role of Patents: the case of CRISPR-Cas9' (2022). European Journal of Health Law. Vol. 29: 543-561. https://doi.org/10.1163/15718093-bja10075
  • 'Reasonable trust through deliberative engagement: the cases of vaccines and genome editing' Social Epistemology' (2022) Vol 36(1) (January): https://doi.org/10.1080/02691728.2021.2009590
  • ‘No Nation Has Conquered Covid’ Arthur L. Caplan, Nicholas Agar, Oliver Feeney, and Vojin Rakic [Commentary article] Barron’s Magazine. Dow Jones & Company, Inc. (Dec. 1, 2021). Available at: https://www.barrons.com/articles/no-nation-has-conquered-covid-51638300074
  • ‘Ethics, patents & genome editing: A critical assessment of three options of technology governance’, Oliver Feeney, Julian Cockbain & Sigrid Sterckx. Frontiers in Political Science Vol 3 (2021) - https://doi.org/10.3389/fpos.2021.731505
  • 'Genome editing and ‘disenhancement’: Considerations on issues of non-identity and genetic pluralism' Oliver Feeney, Vojin Rakic. Humanit Soc Sci Commun 8, 116 (2021). https://doi.org/10.1057/s41599-021-00795-w
  • ‘An EU comparative analysis of the regulation of clinical trials supervisory bodies in the aftermath of Regulation 536/2014’, Iñigo de Miguel Beriain, Theodora Chortara, Aliuska Duardo-Sánchez, Oliver Feeney, Heike Felzmann, Emma Fernández de Uzquiano, Elisa Lievevrouw, Luca Marelli, Titti Mattsson, Janne Rothmar Herrmann, Timo Minssen, Elisabetta Pulice, Vera Lúcia Raposo, Jürgen Robienski, Simone Penasa, Ine Van Hoyweghen. European Public Law 26(2), 307 – 330 (June 2020): [ISSN 1354-3725: https://kluwerlawonline.com/journalarticle/European+Public+Law/26.2/EURO2020046]
  • ‘European electronic Personal Health Records initiatives and vulnerable migrants: a need for greater ELSI safeguards’, Oliver Feeney, Gabriele Werner-Felmayer, Helena Siipi, Markus Frischhut, Silvia Zullo, Ursela Barteczko, Lars Øystein Ursin, Shai Linn, Heike Felzmann, Dušanka Krajnović, John Saunders, and Vojin Rakić. Developing World Bioethics 20(1), 27-37 (March 2020): https://doi.org/10.1111/dewb.12240
  • ‘Regulating germline editing in assisted reproductive technology: An EU cross-disciplinary perspective’, Ana Nordberg, Timo Minssen, Oliver Feeney, Iñigo de Miguel Beriain, Lucia Galvani, Kirmo Wartiovaara. Bioethics 34(1), 16-32 (January 2020): https://doi.org/10.1111/bioe.12705
  • ‘Editing the gene-editing debate: re-assessing the normative discussions on emerging genetic technologies’, NanoEthics: Studies of New and Emerging Technologies 13(3), 233-243 (December 2019): https://doi.org/10.1007/s11569-019-00352-5
  • ‘Response to Open Peer Commentaries on “Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies”’, Oliver Feeney, Julian Cockbain, Michael Morrisson, Lisa Diependaele, Kristof Van Assche & Sigrid Sterckx The American Journal of Bioethics, 19(1) (January 2019), The American Journal of Bioethics, 19:1, W10-W13: https://doi.org/10.1080/15265161.2018.1538395
  • ‘Commentary: enlightened democracy in practice’, Cambridge Quarterly of Healthcare Ethics Vol. 28, No. 1 (January 2019), 89-92: https://doi.org/10.1017/S0963180118000415
  • ‘Patenting foundational technologies: Lessons from CRISPR and other core biotechnologies’, Oliver Feeney, Julian Cockbain, Michael Morrisson, Lisa Diependaele, Kristof Van Assche & Sigrid Sterckx The American Journal of Bioethics, 18(12) (December 2018), 36-48: https://doi.org/10.1080/15265161.2018.1531160
  • ‘Perceptions of Students in Health and Molecular Life Sciences regarding Pharmacogenomics and Personalized Medicine’, Lejla Mahmutovic, Betul Akcesme, Camil Durakovic, Faruk Berat Akcesme, Aida Maric, Muhamed Adilovic, Nour Hamad, Matthias Wjst, Oliver Feeney and Sabina Semiz, Human Genomics, 12(50) (November 2018): https://doi.org/10.1186/s40246-018-0182-2
  • ‘Genuine participation in participant-centred research initiatives: the rhetoric and the potential reality’ Oliver Feeney, Pascal Borry, Heike Felzmann, Lucia Galvagni, Ari Haukkala, Salvör Nordal, Vojin Rakić, Brígida Riso, Sigrid Sterckx and Danya Vears. Special Issue of Journal of Community Genetics Vol. 9, No. 2 (April 2018), 133-142: https://doi.org/10.1007/s12687-017-0342-4
  • ‘The challenges of the expanded availability of genomic information. An agenda-setting paper’ Pascal Borry, Heidi Beate Bentzen, Isabelle Budin-Ljøsne, Martina C. Cornel, Heidi Carmen Howard, Oliver Feeney, Leigh Jackson, Jane Kaye, Deborah Mascalzoni, Alvaro Mendes, Salvor Nordal, Borut Peterlin, Emmanuelle Rial-Sebbag, Brigida Riso, Mahsa Shabani, Heather Skirton, Sigrid Sterckx, Danya Vears, Matthias Wjst and Heike Felzmann. Special Issue of Journal of Community Genetics, Vol. 9, No. 2 (April 2018), 103-116: https://doi.org/10.1007/s12687-017-0331-7
  • ‘Egalitarianism and the Parfitian Equality-Priority Framework’ [Spanish title: El igualitarismo según Derek Parfit: Una discusión], Aesthetika: international journal of interdisciplinary research on subjectivity, politics and art Vol. 13, No. 2 (Sept. 2017), 65-75 ISSN 1553-5053. Available at: http://www.aesthethika.org/IMG/pdf/65-75_feeney_el_igualitarismo_a_la_luz.pdf
  • ‘Incentives, Genetics and the Egalitarian Ethos’, Ethical Perspectives Vol. 19, No. 1 (March. 2012), 83-102: https://doi.org/10.2143/EP.19.1.2152680
  • ‘Germ-line enhancements, Inequalities and the (In) egalitarian Ethos’, Studies in Ethics, Law and Technology: Vol. 4, No. 2 (Aug. 2010) Article 2: https://doi.org/10.2202/1941-6008.1122
  • ‘Equality of Whom? A genetic perspective on equality (of opportunity)’, Res Publica: A Journal of Legal and Social Philosophy Vol. 12, No. 4 (Dec. 2006), 357-383: https://doi.org/10.1007/s11158-006-9017-4
  • ‘Response to Nuffield Council on Bioethics’ Genome editing and human reproduction: open call for evidence’, Ana Nordberg, Timo Minssen, Iñigo de Miguel Beriain, Kirmo Wartiovaara, Lucia Galvagni & Oliver Feeney (Contribution acknowledged in the 2018 Nuffield Report on Genome editing and human reproduction: social and ethical issues). Available at: http://nuffieldbioethics.org/wp-content/uploads/CHIPME-response.pdf
  • Publikationen
  • Member of the Royal Irish Academy Life and Health Sciences Committee: 2022 – 2026 [Working Group leader on genomics and bioethics]
  • Member and Secretary of the Royal Irish Academy Life and Medical Sciences Committee: 2018 – 2022.
  • Working Group member 'Regulatory, Technological Transfer & Industry' in COST Action CA21113 - Genome Editing to Treat Humans Diseases